The Myeloma Institute at the University of Arkansas for Medical Sciences is an international leader in the treatment and research of multiple myeloma and related plasma cell disorders. Patients travel from every state in the United States and from more than 50 countries to receive the latest and most promising treatments in Little Rock, Arkansas. Our clinicians and scientists used advanced knowledge of cancer biology and the latest genomic tools to develop new and targeted treatment strategies to increase survival, cure disease, and improve the quality of life for patients around the globe.